Application

19273244 · CLDN18.2-TARGETING ANTIBODY, BISPECIFIC ANTIBODY AND USE THEREOF

Filed 2025-07-18 · Pending The official file ↗ · Art unit OPAP · Examiner Docket Central Easy · CPC C07K 16/28 · HARBOUR BioMed (Shanghai) Co., Ltd · ASTRAZENECA MEDIMMUNE

Office actions

first was

RCEs

no appeal

To first action

n/a

to disposition n/a

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.